Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pontiano Kaleebu

Showing results (1-10 of 361) with videos related to

Pageof 37
Sort By:
AIDS (London, England)|November 3, 2010
HIV vaccines: current status worldwide and in AfricaPatricia E Fast, Pontiano Kaleebu
Current Opinion in HIV and AIDS|March 19, 2019
HIV subtype diversity worldwideNicholas Bbosa, Pontiano Kaleebu, Deogratius Ssemwanga
JAMA|January 15, 2009
Estimating incidence of HIV infection in UgandaJim Todd, Tom Lutalo, Pontiano Kaleebu
AIDS Research and Human Retroviruses|July 23, 2020
Short Communication: Choosing the Right Program for the Identification of HIV-1 Transmission Networks from Nucleotide Sequences Sampled from Different PopulationsNicholas Bbosa, Deogratius Ssemwanga, Pontiano Kaleebu
Journal of the International AIDS Society|November 19, 2008
Prevention of the sexual transmission of HIV-1: preparing for successMyron S Cohen, Pontiano Kaleebu, Thomas Coates
Microbial Genomics|March 20, 2025
The utility of integrating nanopore sequencing into routine HIV-1 drug resistance surveillanceDaniel Bugembe Lule, Deogratius Ssemwanga, Pontiano Kaleebu, et al.
International Journal of Epidemiology|November 19, 2002
Human immunodeficiency virus type 1 Western blot: revised diagnostic criteria with fewer indeterminate results for epidemiological studies in AfricaCédric Mahé, Pontiano Kaleebu, Amato Ojwiya, et al.
Vaccine: X|August 9, 2023
Vaccination against SARS-CoV-2 in a rural Ugandan populationJoseph Mugisha, Bernard Mpairwe, Beatrice Kimono, et al.
The Pan African Medical Journal|August 1, 2018
Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011Patrick Kazooba, Billy Nsubuga Mayanja, Jonathan Levin, et al.
Vaccines|November 11, 2022
An Overview of Rift Valley Fever Vaccine Development StrategiesPaul Kato Kitandwe, Paul F McKay, Pontiano Kaleebu, et al.
Pageof 37

Showing results (1-10 of 361) with videos related to

Sort By:
Pageof 37
AIDS (London, England)|November 3, 2010
HIV vaccines: current status worldwide and in AfricaPatricia E Fast, Pontiano Kaleebu
Current Opinion in HIV and AIDS|March 19, 2019
HIV subtype diversity worldwideNicholas Bbosa, Pontiano Kaleebu, Deogratius Ssemwanga
JAMA|January 15, 2009
Estimating incidence of HIV infection in UgandaJim Todd, Tom Lutalo, Pontiano Kaleebu
AIDS Research and Human Retroviruses|July 23, 2020
Short Communication: Choosing the Right Program for the Identification of HIV-1 Transmission Networks from Nucleotide Sequences Sampled from Different PopulationsNicholas Bbosa, Deogratius Ssemwanga, Pontiano Kaleebu
Journal of the International AIDS Society|November 19, 2008
Prevention of the sexual transmission of HIV-1: preparing for successMyron S Cohen, Pontiano Kaleebu, Thomas Coates
Microbial Genomics|March 20, 2025
The utility of integrating nanopore sequencing into routine HIV-1 drug resistance surveillanceDaniel Bugembe Lule, Deogratius Ssemwanga, Pontiano Kaleebu, et al.
International Journal of Epidemiology|November 19, 2002
Human immunodeficiency virus type 1 Western blot: revised diagnostic criteria with fewer indeterminate results for epidemiological studies in AfricaCédric Mahé, Pontiano Kaleebu, Amato Ojwiya, et al.
Vaccine: X|August 9, 2023
Vaccination against SARS-CoV-2 in a rural Ugandan populationJoseph Mugisha, Bernard Mpairwe, Beatrice Kimono, et al.
The Pan African Medical Journal|August 1, 2018
Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011Patrick Kazooba, Billy Nsubuga Mayanja, Jonathan Levin, et al.
Vaccines|November 11, 2022
An Overview of Rift Valley Fever Vaccine Development StrategiesPaul Kato Kitandwe, Paul F McKay, Pontiano Kaleebu, et al.
Pageof 37